Skip to main content
TWST
NASDAQ Life Sciences

Officer & Director Emily Leproust Files Intent to Sell $1.6M in Shares

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$64.17
Mkt Cap
$3.996B
52W Low
$23.3
52W High
$66.94
Market data snapshot near publication time

Summary

An Officer and Director of Twist Bioscience Corp has filed an intent to sell $1.63 million in company stock, continuing a pattern of executive share sales.


Key Events

  • Officer & Director Files Intent to Sell

    Emily M. Leproust, an Officer and Director, has filed a Form 144 indicating an intent to sell 25,017 shares of common stock, valued at approximately $1,633,407.23.

  • Continuation of Recent Sales Pattern

    This proposed sale follows previous sales by Ms. Leproust totaling 50,133 shares for gross proceeds of $3,059,801.27 over the past three months, indicating an ongoing distribution trend by a key executive.

  • Selling Near 52-Week Highs

    The intent to sell comes as Twist Bioscience stock is trading near its 52-week high of $66.94, suggesting the executive is capitalizing on the stock's strong performance.


Analysis

Emily M. Leproust, an Officer and Director, has filed an intent to sell an additional $1.63 million worth of common stock. This proposed sale follows approximately $3.06 million in sales by Leproust over the past three months, indicating a consistent pattern of distribution by a key executive. The selling activity occurs while the stock is trading near its 52-week high, which could be interpreted as an executive locking in gains, but also represents a reduction in insider ownership during a period of strong stock performance.

At the time of this filing, TWST was trading at $64.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4B. The 52-week trading range was $23.30 to $66.94. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TWST - Latest Insights

TWST
May 27, 2026, 4:26 PM EDT
Filing Type: 144
Importance Score:
7
TWST
May 04, 2026, 4:31 PM EDT
Source: Wiseek News
Importance Score:
7
TWST
May 04, 2026, 4:28 PM EDT
Filing Type: 10-Q
Importance Score:
7
TWST
May 04, 2026, 7:21 AM EDT
Filing Type: 8-K
Importance Score:
7
TWST
May 04, 2026, 7:19 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
TWST
Feb 17, 2026, 5:27 PM EST
Filing Type: 144
Importance Score:
7
TWST
Feb 17, 2026, 5:09 PM EST
Filing Type: 144
Importance Score:
8
TWST
Feb 17, 2026, 4:42 PM EST
Filing Type: 144
Importance Score:
7
TWST
Feb 17, 2026, 7:36 AM EST
Filing Type: 424B7
Importance Score:
8
TWST
Feb 17, 2026, 7:09 AM EST
Filing Type: 8-K
Importance Score:
8